Eterna Therapeutics Stock Price on December 27, 2024
| ERNA Stock | USD 0.23 0.03 9.62% |
Below is the normalized historical share price chart for Eterna Therapeutics extending back to August 29, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eterna Therapeutics stands at 0.23, as last reported on the 25th of March, with the highest price reaching 0.27 and the lowest price hitting 0.24 during the day.
If you're considering investing in Eterna Stock, it is important to understand the factors that can impact its price. Eterna Therapeutics appears to be out of control, given 3 months investment horizon. Eterna Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0291, which denotes the company had a 0.0291 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Eterna Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Eterna Therapeutics' Downside Deviation of 8.29, mean deviation of 6.58, and Coefficient Of Variation of 2384.75 to check if our risk estimates are consistent with your expectations.
As of March 25, 2025, Total Stockholder Equity is expected to decline to about 1.6 M. In addition to that, Common Stock Shares Outstanding is expected to decline to about 13 M. At present, Eterna Therapeutics' Price Book Value Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 4.16, whereas Price To Sales Ratio is forecasted to decline to 6.55. Eterna Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of October 1992 | 200 Day MA 1.0334 | 50 Day MA 0.34 | Beta 7.329 |
Eterna |
Sharpe Ratio = 0.0291
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ERNA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.09 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Eterna Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eterna Therapeutics by adding it to a well-diversified portfolio.
Price Book 8.1318 | Enterprise Value Ebitda (0.29) | Price Sales 23.3396 | Shares Float 16.9 M | Wall Street Target Price 3 |
Related Headline
Relay Therapeutics Headline on 27th of December 2024
Disposition of 400 shares by Peter Rahmer of Relay Therapeut... by Peter Rahmer
Filed transaction by Relay Therapeutics Officer: See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Eterna Therapeutics Valuation on December 27, 2024
It is possible to determine the worth of Eterna Therapeutics on a given historical date. On December 27, 2024 Eterna was worth 0.29 at the beginning of the trading date compared to the closed value of 0.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eterna Therapeutics stock. Still, in general, we apply an absolute valuation method to find Eterna Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eterna Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eterna Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.25 | 0.30 | 0.24 | 0.28 | 608,100 | |
12/27/2024 | 0.29 | 0.29 | 0.25 | 0.25 | 338,000 |
| 0.28 | 0.34 | 0.27 | 0.28 | 1,421,200 |
| Backtest Eterna Therapeutics | | | Eterna Therapeutics History | | | Eterna Therapeutics Valuation | Previous | Next |
Eterna Therapeutics Trading Date Momentum on December 27, 2024
| On December 30 2024 Eterna Therapeutics was traded for 0.28 at the closing time. The top price for the day was 0.34 and the lowest listed price was 0.27 . The trading volume for the day was 1.4 M. The trading history from December 30, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 12.00% . The overall trading delta against the current closing price is 20.00% . |
Eterna Therapeutics Fundamentals Correlations and Trends
By evaluating Eterna Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eterna Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eterna financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Eterna Therapeutics Stock history
Eterna Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eterna is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eterna Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eterna Therapeutics stock prices may prove useful in developing a viable investing in Eterna Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 13.6 M | 13 M | |
| Net Loss | -22.1 M | -21 M |
Eterna Therapeutics Stock Technical Analysis
Eterna Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Eterna Therapeutics Period Price Range
Low | March 25, 2025
| High |
0.00 | 0.00 |
Eterna Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Eterna Therapeutics March 25, 2025 Market Strength
Market strength indicators help investors to evaluate how Eterna Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eterna Therapeutics shares will generate the highest return on investment. By undertsting and applying Eterna Therapeutics stock market strength indicators, traders can identify Eterna Therapeutics entry and exit signals to maximize returns
Eterna Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eterna Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Eterna Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eterna to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.047 | |||
| Jensen Alpha | 0.4639 | |||
| Total Risk Alpha | 0.8715 | |||
| Sortino Ratio | 0.0574 | |||
| Treynor Ratio | 0.6374 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Eterna Stock analysis
When running Eterna Therapeutics' price analysis, check to measure Eterna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eterna Therapeutics is operating at the current time. Most of Eterna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Eterna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eterna Therapeutics' price. Additionally, you may evaluate how the addition of Eterna Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |